BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Lung cancer AND BRCA2, FAD, 675, ENSG00000139618, FACD, FAD1, FANCD, FANCD1, BRCC2, RP11-298P3_4
75472 results:

  • 1. [Effect of transcutaneous electrical acupoint stimulation on postoperative cough in lung cancer patients undergoing video-assisted thoracoscopic surgery].
    Wang P; Huang M; Xu H; Liu Y; Jia S
    Zhongguo Zhen Jiu; 2024 May; 44(5):521-5. PubMed ID: 38764101
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Predictive value of radiomic features extracted from primary lung adenocarcinoma in forecasting thoracic lymph node metastasis: a systematic review and meta-analysis.
    Wu T; Gao C; Lou X; Wu J; Xu M; Wu L
    BMC Pulm Med; 2024 May; 24(1):246. PubMed ID: 38762472
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Global burden and strength of evidence for 88 risk factors in 204 countries and 811 subnational locations, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021.
    GBD 2021 Risk Factors Collaborators
    Lancet; 2024 May; 403(10440):2162-2203. PubMed ID: 38762324
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. cancer survival in sub-Saharan Africa (SURVCAN-3): a population-based study.
    Joko-Fru WY; Bardot A; Bukirwa P; Amidou S; N'da G; Woldetsadik E; Chesumbai G; Korir A; Kamaté B; Koon M; Hansen R; Finesse A; Somdyala N; Chokunonga E; Chigonzoh T; Liu B; Kantelhardt EJ; Parkin DM; Soerjomataram I
    Lancet Glob Health; 2024 Jun; 12(6):e947-e959. PubMed ID: 38762297
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Identification of patients' smoking status using an explainable AI approach: a Danish electronic health records case study.
    Ebrahimi A; Henriksen MBH; Brasen CL; Hilberg O; Hansen TF; Jensen LH; Peimankar A; Wiil UK
    BMC Med Res Methodol; 2024 May; 24(1):114. PubMed ID: 38760718
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Safety and efficacy of inebilizumab for the treatment of neuromyelitis optica spectrum disorder: end-of-study results from the open-label period of the N-MOmentum trial.
    Cree BAC; Kim HJ; Weinshenker BG; Pittock SJ; Wingerchuk DM; Fujihara K; Paul F; Cutter GR; Marignier R; Green AJ; Aktas O; Hartung HP; She D; Rees W; Smith M; Cimbora D; Katz E; Bennett JL;
    Lancet Neurol; 2024 Jun; 23(6):588-602. PubMed ID: 38760098
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Strategies to address recruitment to a randomised trial of surgical and non-surgical treatment for cancer: results from a complex recruitment intervention within the Mesothelioma and Radical Surgery 2 (MARS 2) study.
    Mills N; Farrar N; Warnes B; Ashton KE; Harris R; Rogers CA; Lim E; Elliott D
    BMJ Open; 2024 May; 14(5):e079108. PubMed ID: 38760029
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Association of Remote Patient-Reported Outcomes and Step Counts With Hospitalization or Death Among Patients With Advanced cancer Undergoing Chemotherapy: Secondary Analysis of the PROStep Randomized Trial.
    Manz CR; Schriver E; Ferrell WJ; Williamson J; Wakim J; Khan N; Kopinsky M; Balachandran M; Chen J; Patel MS; Takvorian SU; Shulman LN; Bekelman JE; Barnett IJ; Parikh RB
    J Med Internet Res; 2024 May; 26():e51059. PubMed ID: 38758583
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. The later-line efficacy and safety of immune checkpoint inhibitors plus anlotinib in EGFR-mutant patients with EGFR-TKI-resistant NSCLC: a single-center retrospective study.
    Yin X; Liu X; Ren F; Meng X
    Cancer Immunol Immunother; 2024 May; 73(7):134. PubMed ID: 38758372
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Exploring Guolin Qigong (Mind-Body Exercise) for Improving cancer Related Fatigue in cancer Survivors: A Mixed Method Randomized Controlled Trial Protocol.
    Low SLK; Ho GF; Liu B; Koh ES; Fei Y; Teo CS; Zhu X
    Integr Cancer Ther; 2024; 23():15347354241252698. PubMed ID: 38757745
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Clinic information, pathological, and imaging characteristics in 2 058 surgical patients with lung cancer from a single center.
    Long B; Xiong Z; Liu S; Cheng Y; Li M; Liao W
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2024 Feb; 49(2):247-255. PubMed ID: 38755720
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Scoping review of exposure questionnaires and surveys in interstitial lung disease.
    Barnes H; Elmrayed S; Barber CM; Feary J; Lee CT; Gandhi S; Peters CE; Salisbury ML; Johannson KA
    BMJ Open Respir Res; 2024 May; 11(1):. PubMed ID: 38754906
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Non-Small Cell lung cancer, Version 4.2024.
    Riely GJ; Wood DE; Ettinger DS; Aisner DL; Akerley W; Bauman JR; Bharat A; Bruno DS; Chang JY; Chirieac LR; DeCamp M; Desai AP; Dilling TJ; Dowell J; Durm GA; Gettinger S; Grotz TE; Gubens MA; Juloori A; Lackner RP; Lanuti M; Lin J; Loo BW; Lovly CM; Maldonado F; Massarelli E; Morgensztern D; Mullikin TC; Ng T; Owen D; Owen DH; Patel SP; Patil T; Polanco PM; Riess J; Shapiro TA; Singh AP; Stevenson J; Tam A; Tanvetyanon T; Yanagawa J; Yang SC; Yau E; Gregory KM; Hang L
    J Natl Compr Canc Netw; 2024 May; 22(4):249-274. PubMed ID: 38754467
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Second Chance for Cure: Stereotactic Ablative Radiotherapy in Oligometastatic Disease.
    Salim N; Tumanova K; Popodko A; Libson E
    JCO Glob Oncol; 2024 May; 10():e2300275. PubMed ID: 38754052
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Real-world osimertinib pretreatment experience in patients with epidermal growth factor receptor T790M mutation-positive locally advanced or metastatic non-small cell lung cancer.
    Chang GC; Shih JY; Yu CJ; Chao HS; Yang CT; Lin CC; Hung JY; Hsiao SY; Wang CC; Chian CF; Hsia TC; Chen YM
    PLoS One; 2024; 19(5):e0303046. PubMed ID: 38753697
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Deep-Learning Model Prediction of Radiation Pneumonitis Using Pretreatment Chest Computed Tomography and Clinical Factors.
    Lee JH; Kang MK; Park J; Lee SJ; Kim JC; Park SH
    Technol Cancer Res Treat; 2024; 23():15330338241254060. PubMed ID: 38752262
    [No Abstract]    [Full Text] [Related]  

  • 17. Evaluation of sex inequity in lung-cancer-specific survival.
    Lærum D; Strand TE; Brustugun OT; Gallefoss F; Falk R; Durheim MT; Fjellbirkeland L
    Acta Oncol; 2024 May; 63():343-350. PubMed ID: 38751329
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. The prevalence and mortality risks of PRISm and COPD in the United States from NHANES 2007-2012.
    Cadham CJ; Oh H; Han MK; Mannino D; Cook S; Meza R; Levy DT; Sánchez-Romero LM
    Respir Res; 2024 May; 25(1):208. PubMed ID: 38750492
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Implications of GCLC in prognosis and immunity of lung adenocarcinoma and multi-omics regulation mechanisms.
    Huang Z; Liang F; Wu J; Huang Z; Li Y; Huang X; Liu Z
    BMC Pulm Med; 2024 May; 24(1):239. PubMed ID: 38750474
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Understanding the interplay of colorectal cancer awareness and attitudes among Palestinians: a national cross-sectional study.
    Elshami M; Dwikat MF; Al-Slaibi I; Alser M; Albandak ME; Ayyad M; Naji SA; Mohamad BM; Isleem WS; Shurrab A; Yaghi B; Qabaja YA; Hamdan FK; Sweity RR; Jneed RT; Assaf KA; Hmaid MM; Awwad II; Alhabil BK; Alarda MN; Alsattari AS; Aboyousef MS; Aljbour OA; AlSharif R; Giacaman CT; Alnaga AY; Nemer RMA; Almadhoun NM; Skaik SM; Albarqi SI; Abu-El-Noor N; Bottcher B
    BMC Cancer; 2024 May; 24(1):590. PubMed ID: 38750448
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 3774.